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On healing, partial-thickness burn wounds usually result in depigmentation of the skin. 
This is due to the loss of melanocytes. The lack of pigmentation in the healed wound is 
particularly prominent in dark-skinned individuals and could result in serious 
psychosocial consequences such as low self-esteem, stigmatisation and discrimination 
among sufferers. Methods aimed at investigating rapid and efficient repigmentation in 
wounded skin are therefore pertinent. The aims of this study were two-fold: 
i) To promote melanin synthesis in human skin cells using different ratios of 
human melanocytes (Mc) to keratinocytes (Kc) in an in vitro co-culture 
system, in order to ensure pigmentation of the skin and,  
ii) To understand cellular mechanisms that contribute basic scientific 
knowledge towards clinically improved wound healing  
 
METHODS:  
Ethically obtained, normal human-derived cells were co-cultured at 3 different ratios, 
5Kc:1Mc (5:1), 10:1 and 20:1. Tyrosinase protein expression and activity were analysed 
by western blot and tyrosinase assays, respectively. Melanin assays were used to 
quantify the amount of melanin produced in these co-cultures. Furthermore, the 
morphology of the melanocytes was determined by quantification of the average 
number and length of dendrites per melanocyte. Scratch assays were performed to 
simulate a wounded skin to observe the rate of wound healing over a 4 to 48 hour 
period. Fluorescence microscopy was done to quantify the percentage of proliferating 
melanocytes in the proximity of the scratched area. 
 
RESULTS:  
Western blots confirmed the presence of tyrosinase in the ratios. Interestingly, the 
tyrosinase expression and activity appeared to be the same between the 3 ratios. We 














of melanin in our co-cultures. There were no morphological differences between the 
melanocytes cultured at the different ratios as no change was detected in dendrite 
number and length. In terms of wound closure between the ratios, there was no 
difference in the rate of migration of the epidermal cells and the percentage of 
proliferating melanocytes.   
 
CONCLUSION:  
Overall, our results suggest that since there is no difference in the level of cellular 
pigmentation as well as wound healing, the 20:1 ratio of epidermal keratinocytes to 
melanocytes could be optimally used to enhance autologous cellular grafting. This 
information is considered an important contribution towards clinical application and to 














CHAPTER 1: LITERATURE REVIEW 
 
“I am healed but I am still different” – Sipho, 7 years old;  
Red Cross War Memorial Children’s Hospital 
These words echo the ongoing problem for burn victims leaving South African 
hospitals. Burns cases are rapidly increasing across Africa. Statistics show that it is one 
of the regions with the highest mortality rates as a result of fire-related injuries, with 6.1 
deaths per 100000 individuals (Mock et al., 2008). In South Africa, 3.2% of the 
population sustains burn injuries annually (Albertyn et al., 2006), with recent data from 
Mpumalanga showing that burn fatalities are highest amongst children below 4 years of 
age and adults over the age of 25 (Blom et al., 2011). In the Western Cape, data 
collected from 1997-2006 of paediatric injuries admitted to the Red Cross War 
Memorial Children’s Hospital in Cape Town, showed a statistic of 8.8% that was due to 
burn injuries, which was the 4
th
 most common injury (Herbert et al., 2012). The 
Tygerberg hospital burn unit recorded that 1908 patients were admitted from the period 
of 2003-2008 (Maritz et al., 2012). This alarming trend was due to poverty, mass 
illiteracy, the increase in the informal settlement including the design of informal 
shacks, with the use of open fires as well as lifestyle factors such as alcohol usage 
(Albertyn et al., 2006, Oluwasanmi, 1969, Van Niekerk et al., 2009, Niekerk et al., 
2006). The most commonly affected areas on the body are the face, hands and feet 
(Cahill et al., 2008). Often the wound treatment regimes include autologous grafting, 
where the patients’ own skin is used to cover the burn area. However, although a healed 














reflecting a sub-optimal healing response and leading to someone such as Sipho, stating 
“I am healed, but I am still different”. In addition, the contrast between pigmented and 
non-pigmented areas is most striking in dark-skinned individuals (Kahn et al., 1996). 
Although partial-thickness burn wounds are not life-threatening, they result in a number 
of psychosocial consequences, where stigmatism, low self-esteem and discrimination 
are part of everyday life (Dyster-Aas et al., 2008, Ter Smitten et al., 2011). In light of 
this, an understanding of the skin and its healing response at a cellular, holistic and 
individualistic level becomes highly pertinent. We believe that this knowledge will 
contribute to an optimal healing outcome.  
  
1.1 The problem 
 
Even though treatments for partial-thickness burns are available, the remaining problem 
is that once the wound has healed, the outcome is often sub-optimal as the burned area 
remains hypopigmented and pink in colouration. This is a clinical problem, as the skin 
needs to be protected from ultraviolet radiation (UVR) by the pigments produced in the 
melanocytes (Eves et al., 2005), and yet only keratinocytes are used to heal burn 
wounds to restore the barrier function of the skin (MacNeil, 2007). Furthermore, the 
discolouration gives the perception that although the wound is healed, there is still 
something lacking. This change in appearance results in serious psychosocial 
consequences such as depression (Dyster-Aas et al., 2008, Ter Smitten et al., 2011, 
Chadwick et al., 2012). Moreover, burned children are often left permanently disfigured 
for life. The disfigurement (and consequent distress) is especially evident in the darker 














and the normally pigmented skin is particularly apparent (Kahn et al., 1996). The main 
reason for this is that clinicians tend to concentrate, and rightly so, on the speed of 
healing related to keratinocyte closure, which entails the migration of keratinocytes into 
the wounded area by the formation of lamellipodia (Odland et al., 1968). Lamellipodia 
are the thin cytoplasmic extensions from the front of the cell, which gives the cell a 
ruffled edge appearance (Small et al., 2002). For repigmentation, the presence of 
melanocytes needs to be included in wound healing treatments. Moreover, melanocytes 
are needed in the environment of the keratinocytes (Imokawa et al., 1998, Plonka et al., 
2009). Proliferation of melanocytes is under the control of keratinocytes. In order to 
proliferate, a model has been proposed whereby the melanocytes first retract their 
dendrites and detach themselves from the surrounding keratinocytes and the basement 
membrane, followed by proliferation and then migration along the basement membrane. 
The last step is to extend their dendrites and reattach themselves to the keratinocytes 
(Santiago-Walker et al., 2009). 
 
In a case study by Back et al. (2009), when the authors attempted transplantation of 
melanocytes and keratinocytes onto depigmented area, they noted that the 
repigmentation was unpredictable (Back et al., 2009). In light of this, we were 
interested to find out if transplantation of a certain melanocyte to keratinocyte ratio 
could improve the level of pigmentation as well as contribute to a better healing 
outcome. Hence, the overall aim of this project was to promote melanin synthesis in 
order to repigment the skin in an in vitro culture system using different ratios of 
keratinocytes to melanocytes. These ratios included - 5 keratinocytes: 1 melanocyte 














would produce a better outcome of pigmentation and at the same time, lead to improved 
wound healing. The comparison of 3 different ratios, to our knowledge, with regards to 
the pigmentary phenotype and wound healing, has never been shown before.  
 
1.2 Burn wounds 
 
Burn wounds are classified into 3 types - superficial (first degree), partial-thickness 
(second degree) and full-thickness (third degree) burns (Fig. 1.1). Superficial burns 
affect only the epidermis and are treated non-operatively and usually heal without 
scarring. A wound is classified as partial-thickness when the injury extends into the 
dermis. Full-thickness burns penetrate into the deeper portion of the dermis and causes 
damage to the muscle, bones and nerves (Johnson et al., 2003). This project focuses on 


















Partial-thickness burns occur predominantly on the fingers, hands, wrists, feet and 
ankles (Kahn et al., 1996). The number of burn cases in Sub-Saharan Africa is 
particularly alarming, especially in paediatric burns (Mock et al., 2008, Albertyn et al., 
2006, Herbert et al., 2012, Maritz et al., 2012). Treatment options for partial-thickness 
burns include surgical and non-surgical methods. Non-surgical methods include the use 
of antibiotics, biological or non-biological dressings (Johnson et al., 2003, Maghsoudi 
et al., 2011, Peura et al., 2012, Juhasz et al., 2010, Magliacani, 1990), whereas surgical 
methods consist of skin grafts. Unfortunately, there is a serious lack of sufficient 
specialised treatment centres available for burn patients, especially in South Africa 
(Sowemimo, 1993). If these specialised skin grafting facilities are available, there is a 
deficiency of blood products and staff shortages, such as anaesthetists. The Red Cross 
War Memorial Children’s hospital in Cape Town, consisting of 22 beds for burn cases 
(Cahill et al., 2008), is the only unit that offers specialised treatment to children under 
the age of 13 (http://childrenshospitaltrust.org.za/c2-burns-unit/). In India, a large 
incidence of burns leads to a huge financial strain on an already overburdened health 
system. Hence, there is a need to reduce the cost of the therapy by closing the wound as 
early as possible without infection. This was first performed with the use of amniotic 
membranes. The authors found a reduction in pain and the wound healed more rapidly 
due to the oestrogen in the membrane (Ramakrishnan et al., 1997). 
 
In order for us to achieve the aims set out in this project, this literature review will 
highlight the background knowledge that is relevant to the skin, and the cells in the 
epidermal layer, such as the melanocytes and keratinocytes. It will provide a brief 














process. Lastly, this literature review will shed light on the morphology of the 
melanocytes, specifically the dendrites, and also the mechanism of repigmentation in 
the skin.  
 
1.3 The skin 
 
The skin is the largest organ of the body, with its primary function being a protective 
barrier – protecting the body from the external environment (Stenn et al., 1992). It 
consists of 2 layers – the deeper layer is the dermis, overlaid by the epidermis (Fig. 1.2). 
The dermis, containing fibroblasts, nerves, blood vessels, adipose and connective tissue; 
can be further subdivided into 2 areas, where the lower part is predominantly composed 
of adipose tissue. The uppermost epidermal layer consists of Langerhans cells, Merkel 
cells, keratinocytes and melanocytes (Young et al., 2000). Langerhans cells are antigen 
presenting cells that function as sentinels to detect foreign particles or organisms, 
thereby playing an important role in the immunity of the skin (Stenn et al., 1992, 
Williams et al., 1996). Merkel cells are non-neuronal cells that function as touch 
receptors. The keratin-producing keratinocytes make up the majority of the cell 
population in the epidermis; while the melanocytes provide colour to the skin through 
the production of melanin. The predominant cell types of the epidermis, melanocytes 
and keratinocytes, make up the “epidermal unit” with a ratio of 1 melanocyte to 36 
keratinocytes (Fitzpatrick et al., 1963). However, in the basal layer of the epidermis, the 
ratio becomes 1:5 (Santiago-Walker et al., 2009, Fitzpatrick et al., 1979). Although the 














affect the epidermal and upper dermal layers. This necessitates knowledge of the 




Figure 1.2. Basic structure of the skin. [Source: http://fromyourdoctor.com] 
 
 
1.4 Epidermal cells 
 
Melanocytes are neural crest-derived cells (Haake et al., 1999). During human 
embryonic development, melanocyte precursor cells, melanoblasts, migrate to several 
target sites, including the epidermis, dermis, hair follicles, eyes, ears, heart and brain 
where they differentiate into mature melanocytes (Kawa et al., 2000, Kawa et al., 2000, 
Hirobe, 1992). The melanocyte precursor cells undergo differentiation, under the 
control of transcription factors such as SRY (sex determining region Y)-box 10, paired 
box 3 and microphthalmia-associated transcription factor (Hornyak et al., 2001, Potterf 
et al., 2001). In the epidermis, the melanocytes reside in the basal layer, where they 














These dendrites allow for the transfer of lysosomally-derived organelles, melanosomes, 
to the keratinocytes (Orlow, 1995). The process of melanogenesis – formation of 
melanin – takes place in this organelle under the control of the enzyme, tyrosinase. 
Upon being taken up by the keratinocytes, they accumulate over the nucleus, effectively 
protecting the nuclear material against UVR and other DNA-breaking environmental 
factors (Eves et al., 2005, Kobayashi et al., 1998a). Within the melanosome, two types 
of melanin exist – eumelanin, the black/brown pigment; and pheomelanin, the 
red/brown pigment. Surprisingly, the difference in pigmentation between races is not 
due to the number of melanocytes, but rather depends on the amount and type of 
melanin produced; and the difference in size, number and distribution pattern of 
melanosomes within the keratinocytes (Szabo et al., 1969, Tsatmali et al., 2002, Alaluf 
et al., 2003).   
 
 
Figure 1.3. The epidermis showing a melanocyte, with a number of dendrites, surrounded by the 
















The process of melanin formation starts with the rate limiting enzyme, tyrosinase, 
catalysing the hydroxylation of cytoplasmic tyrosine to dihydroxyphenylalanine 
(DOPA) and the subsequent oxidation of DOPA to DOPAquinone (Hearing et al., 
1991). At this point, the pathway splits and the 2 different types of melanin – 
pheomelanin and eumelanin – are produced (Fig. 1.4) (Prota, 1980). Pheomelanin, the 
reddish-brown pigment, is synthesised when DOPAquinone is converted to 
cysteinylDOPA, then 1,4-benzothiazinyl-alanine, by the addition of glutathione or 
cysteine. The brown-black pigment, eumelanin, is synthesised when DOPAquinone is 
spontaneously converted to DOPAchrome. The enzyme dopachrome tautomerase, 
similarly known as tyrosinase-related protein-2 (TRP2), then converts DOPAchrome to 
5,6-dihydroxyindole-5-carboxylic acid (DHICA). DHICA is further oxidised by the 
enzyme tyrosinase-related protein-1 (TRP1) to indole-5,6-quinone-carboxylic acid. 
DOPAchrome can alternatively be spontaneously decarboxylated to 5,6-
dihydroxyindole (DHI) (Jackson et al., 1992, Tsukamoto et al., 1992), which is then 
catalysed to indole-5,6-quinone by tyrosinase (Korner et al., 1982). Indole-5,6-quinone-
carboxylic acid and indole-5,6-quinone are finally polymerised to form eumelanin. 
Whereas, eumelanin is a photoprotective, photostable polymer; pheomelanin, in 
contrast, does not provide much protection against UVR and is considered a 
photosensitiser (Duval et al., 2002). The process of melanogenesis produces many 
“toxic” melanin intermediates/precursors, such as phenols and quinones, which can 
react with and damage the macromolecules within the cells, and as such it is suggested 
that melanin synthesis occurs in melanosomes to protect the melanocytes (Borovansky 















Figure 1.4. Synthesis of eu- and pheomelanin in melanogenesis. [Modified from: Hearing, 2006 and 
Ito et al., 2006] 
 
Despite the mechanism of transfer, when the melanosomes appear in the cytoplasm of 
the keratinocytes, they form a cap over the nucleus to protect the DNA from damage 
caused by UVR (Kobayashi et al., 1998a). Interestingly, in an in vitro study, Minwalla 
et al. (2001) demonstrated that the distribution of melanosomes is dependent on the 
ethnic/racial origin of the keratinocytes, rather than the size of the melanosome. They 
showed that in keratinocytes from light-skinned individuals, 4 to 8 melanosomes were 
distributed in clusters in the perinuclear area. However, melanosomes in keratinocytes 
from dark-skinned individuals were distributed as singular melanosomes (Minwalla et 














individual melanosomes is usually larger, approximately 800 nm in length, compared to 
those found in light-skinned keratinocytes, approximately 400 nm (Szabo et al., 1969, 
Minwalla et al., 2001, Kollias et al., 1991, Konrad et al., 1973). Degradation of 
melanosomes in the keratinocytes is not clearly understood; however in an in vitro 
system using melanosomes isolated from SKMEL-188 melanoma cells or normal 
human melanocytes, it was shown that melanosomes were more rapidly degraded in 
keratinocytes from light-skinned individuals, compared to those from dark skin (Ebanks 
et al., 2011). This could suggest that darker-skinned individuals may have a different 
healing response compared to light-skinned individuals. However, to our knowledge no 
literature corroborates this suggestion.  
 
1.4.1 Proteins and enzymes involved in melanogenesis 
 
As the process of melanogenesis is critical to restoring pigmentation to healing skin, 
knowledge of the proteins involved in this process is essential. Moreover, 
immunocytochemical analyses of healed skin use these proteins as markers of 
differentiated melanocytes. These crucial enzymes involved in melanogenesis are 
tyrosinase, TRP1 and TRP2. The rate-limiting enzyme of the melanogenesis pathway, 
tyrosinase, is a 60 kDa protein that undergoes post-translational modification by 
glycosylation to become a mature enzyme in the endoplasmic reticulum and Golgi 
apparatus.  After glycosylation, the molecular weight of tyrosinase is approximately 70-
80 kDa, depending on the number of sites that have been glycosylated (Ujvari et al., 
2001, Halaban et al., 1997). Tyrosinase has 6 N-linked glycosylation sites and mutation 














melanosomes via clathrin-coated vesicles (Watabe et al., 2004), where tyrosinase 
initiates melanogenesis. Tyrosinase is structurally similar to TRP1 and TRP2, and 
highly conserved between different species (Hearing et al., 1991). Tyrosinase has 
copper ions in its metal binding regions, whereas TRP2 has zinc. The metal co-factor 
for TRP1 is currently unknown. The molecular weight of TRP1, depending on the level 
of glycosylation, and TRP2 are 70-90 kDa and 75 kDa, respectively. All 3 enzymes are 
localised on melanosomal membranes. TRP1 is needed for the correct trafficking of 
tyrosinase into the melanosomes (Toyofuku et al., 2001, Manga et al., 2000) as well as 
stabilising tyrosinase activity (Kobayashi et al., 1998b). TRP2 is involved in tyrosinase 
stabilisation within the melanosome (Manga et al., 2000).  
 
Other proteins involved in melanogenesis include Pmel17, melanoma antigen 
recognised by T-cells 1 (MART-1 or Melan-A) and p protein. Pmel17, also known as 
gp100 or SILV, is a structural protein that forms the fibrils in stage I and II 
melanosomes (pre-melanosomes) (Kushimoto et al., 2001, Berson et al., 2001, 
Yasumoto et al., 2004). MART-1, a hydrophobic transmembrane protein also found in 
the pre-melanosomes, is necessary for melanosome maturation as it regulates the 
expression, stability, trafficking and processing of Pmel17 (Hoashi et al., 2005). P 
protein, found in the melanosome, is needed for the regulation of intramelanosomal pH 




















Dendrites, the cytoplasmic extensions of melanocytes, are an important morphological 
feature that allows the interaction between the cells of the epidermal melanin unit. It is 
also necessary for the transfer of melanosomes from the melanocytes to the 
keratinocytes (Tsatmali et al., 2002, Jeon et al., 2007, Costin et al., 2007). 
Melanogenesis is associated with dendricity in that an increase in the process of 
melanogenesis correlates with an increase in the number and length of the dendrites 
(Kim et al., 2010). It follows therefore that length and number of dendrites reflects the 
differentiated status of the melanocyte. Melanocyte mono-cultures usually display 
characteristic dendrites with short bipolar phenotype. However, in melanocyte and 
keratinocyte co-cultures, the dendrites are typically long and poly-dendritic, extending 
to be in contact with the keratinocytes. Melanocytes that are too far from keratinocytes 
display shorter dendrites compared to those that are in direct contact with the 
keratinocytes (Nakazawa et al., 1995). In studies performed with keratinocyte-
conditioned medium, it was shown that following ultraviolet radiation, keratinocyte-
derived factors were increased which led to increased growth, melanisation and 
dendricity. Keratinocytes produce and secrete many factors, such as α-melanocyte-
stimulating hormone, that are involved in the regulation of melanocyte proliferation, 
pigmentation and influence dendricity (Hunt et al., 1996). Other keratinocyte-derived 
factors include fibroblast growth factor (proliferation), nerve growth factor (Yaar et al., 
1994), prostaglandin E2 (dendricity; (Scott et al., 2007) and endothelin-1 (proliferation, 














Halaban et al., 1988). These factors are therefore very important in the interaction 
between melanocytes and keratinocytes.  
 
1.5 Mechanisms of repigmentation 
 
Melanocyte precursors have been shown definitively to be located in the hair follicle 
bulge which acts as a niche (Nishimura, 2011, Tanimura et al., 2011). For the migration 
of melanocytes into the depigmented areas following wounding, the architecture and 
adhesion mechanisms of the cell and its surrounding matrix need to be altered. The 
extracellular matrix is remodeled to allow the migration of these melanocytes. This 
requires a balance between the synthesis and degradation of collagen, proteoglycan and 
multi-adhesive matrix proteins by matrix metalloproteases and their inhibitors (Kumar 
et al., 2011). Thus, repigmentation occurs due to stimulation and migration of 
melanocyte precursors into the unpigmented regions where they differentiate and 
produce pigment. In the case of burns, the hair follicle is often destroyed. In light of the 
current dogma, this would then lead to a lack of melanocyte precursor cells and an 
associated absence of pigment. However, our finding that glabrous (hair-less), 
vitiliginous skin could repigment after treatment, suggested that melanocyte precursor 
niches possibly also exist outside the hair follicle (Davids et al., 2009). Despite this, 
healed skin remains with a lack of pigmentation, necessitating extra melanocytes to be 
grafted onto the depigmented regions. Options to repigment the skin are available but 
involve surgery. This includes split-thickness skin grafting (Taki et al., 1985), skin chip 
grafting (Harashina et al., 1985), punch grafting (Orentreich et al., 1972, Fujii et al., 














et al., 1985). Punch grafting is performed with the use of a biopsy punch to remove 
small pieces of skin from the donor site, while sheet grafts are larger pieces of skin 
obtained from the donor site with a dermatome. Split-thickness skin grafts using the 
patient’s own skin from a donor site is the gold standard of wound healing (Juhasz et 
al., 2010). However, an advantage of using either cultured or non-cultured autologous 
cellular grafts is that a small donor area can be used to cover a larger recipient area. 
 
Despite the burden of burns remaining a significant problem in South Africa, we believe 
that the approach taken by this project will make an important contribution towards 
clinical application, with respect to increasing the efficacy of autologous cellular 














CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Tissue culture 
 
2.1.1 Primary cells and cell line used 
 
Primary melanocytes were aseptically isolated from human newborn (<1 year) foreskin 
using a modified method described by Eves et al. (2005). Briefly, the samples were 
transported in tubes containing Dulbecco’s Modified Eagle’s medium (DMEM; 
Appendix A.5) with antibiotics (100 U/ml penicillin/100 µg/ml streptomycin; Appendix 
A.1), then cut into 3-5 mm thin strips and placed in 5 mg/ml dispase II (Sigma-Aldrich, 
USA) in Hanks buffered salt solution (Appendix A.2) at 4
o
C overnight. The following 
day, the epidermal sheet was removed with forceps and placed into a drop of phosphate 
buffered saline (PBS, Appendix A.3) and manually disaggregated into smaller pieces 
with a scalpel (KIMIX, RSA) before being transferred into a 0.25% trypsin, 0.05% 
EDTA solution (pH 7.5, Appendix A.4) at 37
o
C. The epidermal sheets were triturated 
every 5 min and after 15 min, 10% Fetal Calf Serum (FCS; GIBCO, USA) was added to 
inactivate the trypsin. The cell suspension was then filtered through a 70 µM cell 
strainer (BD Biosciences, USA) to remove larger pieces of tissue that had not 
dissociated into a cell suspension. After centrifugation at 2000 rpm for 5 min, the cell 
pellet was resuspended in melanocyte growth medium, FETI (Table 2.1) and incubated 
at 37
o
C with 5% CO2/95% O2 (O2/CO2 incubator; Sanyo, Japan)  overnight. No 
















Table 2.1. List of components in the melanocyte growth medium, FETI 
MEDIUM COMPONENT CONCENTRATION SOURCE 
FETI 




Fetal Calf Serum 2% GIBCO, USA  
Ultroser G 1% PALL Life 
Sciences, USA 
Human Fibroblast 
Growth Factor 2 
2 ng/ml Miltenyi Biotec, 
Germany 









0.05 mM Sigma-Aldrich, 
USA 




The spontaneously immortalised human keratinocyte cell line, HaCaT, a gift from Prof 
Fusenig, Germany, was used in all co-cultures with primary human melanocytes 
(Boukamp et al., 1988). Melanocytes and HaCaTs were prepared and grown in their 
own specialised medium. Melanocytes were cultured in FETI medium modified from 
Smit et al. (2008), while HaCaTs were cultured in DMEM. The co-culture medium, 
Greens, modified from Rheinwald and Green (1977) was used when the melanocytes 














al., 1977).  Cells were grown in a humidified incubator (Sanyo, Japan) with 5% 




Table 2.2. List of components in co-culture medium, Greens  
MEDIUM COMPONENT CONCENTRATION SOURCE 
Greens 
DMEM/F12 1:1 GIBCO, USA 
Insulin 5 µg/ml NovoRapid, 
Novo Nordisk 
(Pty) Ltd, RSA 
Hydrocortisone 0.4 µg/ml Sigma-Aldrich, 
USA 
Cholera toxin 0.1 nM Sigma-Aldrich, 
USA 
3, 3’, 5-Trioiodo-L-
thyronine sodium salt 
2 nM Sigma-Aldrich, 
USA 
Transferrin 5 mg/ml Sigma-Aldrich, 
USA 
Epidermal growth factor 10 ng/ml Sigma-Aldrich, 
USA 
Penicillin/streptomycin 100 U/ml; 100µg/ml Sigma-Aldrich, 
USA 
Gentamycin 0.2 mg/ml Sigma-Aldrich, 
USA 
Sodium bicarbonate 0.075% Merck, RSA 
HEPES buffer 20 mM Sigma-Aldrich, 
USA 















2.1.2 Trypsinisation  
 
In order to propagate cells in culture, they are passaged when the tissue culture dishes 
are 80~100 % confluent. This was performed by incubating the primary melanocytes 
with a 0.05 % trypsin/ 0.02% EDTA solution (TE, Appendix A.28) for 3~5 min, 
followed by the addition of FETI to inactivate the trypsin activity. The cells were 
triturated and centrifuged at 2500 rpm for 3 min. The cell pellet was then resuspended in 
FETI and placed in new sterile tissue culture dishes. In the case of passaging the 
HaCaTs, cells were initially incubated with 0.05 % EDTA (Appendix A.27) for 15 min, 
followed by an incubation with TE for 3~5 min. The cells were triturated following the 
addition of DMEM, and then centrifuged. The cell pellet was resuspended in DMEM 
and cells were transferred to new dishes. Trypsinisation of the co-cultures was 
performed similarly to the HaCaTs, however, Greens was used to inactivate the trypsin 
and resuspend the cells.  
 
2.2 Experimental setup 
 
Three ratios of co-cultures of keratinocytes to melanocytes were used. These included 
5:1, 10:1 and 20:1 keratinocytes to melanocytes, respectively. 
 
In the following tables, the numbers of cells seeded for each experiment is shown. The 
number of melanocytes used was kept constant in the different assays shown in Tables 














as the same cell confluency was needed before the scratch (Chapter 2.10) was to be 
performed.  
 
Table 2.3. Number of cells used for senescence-associated beta-galactosidase and dendricity assays 
















Table 2.4. Number of cells used for western blot, melanin and tyrosinase enzymatic activity assays 















Keratinocyte control 2x 10
5
 - 
Melanocyte control - 5x 10
5 
 
Table 2.5. Number of cells used for scratch assays 















Keratinocyte control 1.5x 10
5
 - 















2.3 Senescence-associated beta-galactosidase (SA-βgal) assay 
 
The SA-βgal assay detects cells undergoing senescence and determines whether certain 
morphological aspects can provide an indication of senescent cells (Debacq-Chainiaux 
et al., 2009). Although all cells express β-galactosidase activity, detected at pH 4.0, only 
senescent cells express β-galactosidase activity at pH 6.0. This enzymatic activity can 
be observed when the 5-bromo-4-chloro-3-indoyl β-D-galactopyranoside (X-gal) 
substrate is cleaved by β-galactosidase to form an insoluble blue compound (Dimri et 
al., 1995). In our experimental system, melanocytes, in mono-cultures and co-culture 
with HaCaTs, were seeded onto 35 mm
2
 glass coverslips, allowed to adhere for 48 h, 
washed with 1x PBS (pH 6), and fixed with 4% paraformaldehyde (Merck, Germany; 
Appendix A.6) at room temperature for 15 min. Following further PBS washes, the βgal 
stain (1 mg/ml; Appendix A.7), was added to the cells and incubated at 37
o
C for 12-16 
h. The cells were then washed and mounted onto glass slides with mounting medium, 
mowiol (Appendix A.8), at room temperature overnight. The slides were viewed under 
brightfield at 400 x magnification using the Zeiss Axioskop 200 (Carl Zeiss 
Microscopy, Germany) microscope. Images were captured on AxioCam HR (Carl Zeiss 
Microscopy, Germany) with the associated AxioVision 4.7 software (Carl Zeiss 
Microscopy, Germany). Senescent cells were recognised by a bluish tinge. 
 
2.4 Western blot analyses: Tyrosinase protein expression 
 
Western blot analysis is an indirect method used to detect proteins of interest by 














transfer of the protein onto membranes. This is followed by detection using specific 
antibodies to the protein(s) of interest followed by enhanced chemiluminescence (ECL) 
detection on an x-ray film (Towbin et al., 1979, Alegria-Schaffer et al., 2009). This 
study employed western blots to confirm the presence of tyrosinase protein expression 
in the co-cultures. Briefly, cells were cultured as described in Table 2.4. After the 
experimental period (6 days), proteins were extracted on ice by adding complete radio-
immunoprecipitation assay (RIPA) buffer (Appendix A.10) to the dish of cells. A cell 
scraper was then used to scrape all the cells to the bottom of the angled dish. The lysed 
cells were subsequently transferred to a 1.5 ml microfuge tube, vortexed and placed at   
-80
o
C for 60 min to aid in the removal of contaminating DNA. Once thawed, on ice, the 
samples were centrifuged at 12000 rpm at 4
o
C for 20 min. The supernatant was 
transferred to a clean 1.5 ml microfuge tube and stored at -80
o
C till further analyses 
were conducted. 
 
The protein concentration of the samples was determined using the Pierce BCA Protein 
Assay Kit (Thermo Scientific, USA). This kit is a colorimetric assay whereby a purple-
coloured reaction product is produced when two bicinchoninic acid molecules chelate 
with one cuprous ion. This product is then read spectrophotometrically (Versamax 
microplate reader, Molecular Devices, USA) at 562 nm and compared to a standard 
curve generated using bovine serum albumin (Sigma-Aldrich, USA) at known 
concentrations. The protein concentration of each sample is then calculated using 















Eighty micrograms of protein with an associated quantity of loading dye (Appendix 
A.16) was denatured on the heating block (AccuBlock Digital Dry Bath; Labnet 
International, USA) at 85
o
C for 5 min. Once cooled to room temperature, the protein 
samples, together with the molecular weight peqGOLD protein marker IV (PEQLAB 
Biotechnologie, Germany), were resolved on a 10% SDS-PAGE gel (Appendix A.18) 
with an initial stacking gel (4%, Appendix A.21) at 100 V in running buffer (Appendix 
A.22) and transferred onto a nitrocellulose membrane (Amersham Hybond ECL; GE 
Healthcare, UK) at 100 V in transfer buffer (Appendix A.23) at room temperature for 60 
min using the Mini-PROTEAN Tetra Cell system (Bio-Rad Laboratories, USA). The 
membrane was then rinsed with tris-buffered saline-tween 20 (TBS-T, Appendix A.25) 
solution, blocked with 5% fat-free milk in TBS-T (Appendix A.26) at room temperature 
for 60 min. Tyrosinase was detected by incubating the membrane with an anti-
tyrosinase primary antibody, Table 2.6, at 4
o
C overnight. The following day, the 
membrane was washed with TBS-T, and incubated with the secondary antibody, donkey 
anti-goat conjugated to horseradish peroxidase (Table 2.6), at room temperature for 1 h 
on a shaker. This was followed by another wash with TBS-T and WesternBright ECL 
(Advansta, USA) was added according to manufacturer’s instructions. The membrane 
was then exposed to medical x-ray film (AGFA, Belgium) in the dark, developed 
(AGFA, Belgium) and fixed (AGFA, Belgium) before rinsing with water and air-dried. 
To re-detect another protein, the membrane was “stripped” by several washes in TBS-T. 
The membrane was then incubated with the primary antibody, p38 (Table 2.6), to 
determine the loading control for the proteins. The unphosphorylated p38 is used as a 
control because it is highly expressed and remains constant in cells. The same 














was scanned with G:BOX ChemiXT-16 (SynGene, England) using the GeneSnap 
software (version 7.07, SynGene, England) and analysed for densitometry with 
GeneTools (version 4.00, SynGene, England). 
 







MART-1 (Cat: Melan-A: sc-
20032, Santa Cruz 
Biotechnology, USA) 
1:200 in 10% BSA 
Donkey anti-mouse Alexa-488 
(Cat: NL009, R&D Systems, 
USA) 
1:500 in 10% BSA 
Ki-67 (Cat: ab15580, rabbit 
polyclonal, Abcam, UK) 
1:500 in 10% BSA 
Donkey anti-rabbit Cy-3 
(Cat: 711-166-152, AEC-
Amersham, RSA) 
1:1500 in 10% BSA 
Tyrosinase (C-19; Cat: sc-
7833, Santa Cruz 
Biotechnology, USA) 
1:1000 in 5% fat-free milk 
Donkey anti-goat Horseradish 
peroxidase conjugated (Cat: sc-
2020, Santa Cruz 
Biotechnology, USA) 
1:5000 in 5% fat-free milk 
p38 (Cat: p-38 MAP Kinase: 
MO800 rabbit polyclonal, 
Sigma-Aldrich, Germany) 
1:5000 in TBS-T 
Goat anti-rabbit Horseradish 
peroxidase conjugate (Cat: 170-
6515, Bio-Rad Laboratories, 
USA) 
1:5000 in 5% fat-free milk 
 
 
2.5 Tyrosinase enzyme activity assay 
 
In melanogenesis, tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) and 
then oxidised to DOPAquinone. These initial 2 steps are catalysed by the same enzyme, 
tyrosinase. Since tyrosinase is the rate-limiting enzyme in this pathway, this assay is 
designed to determine the level of enzyme activity with the addition of DOPA and 
radiolabelled 
14
C tyrosine to drive the reaction. The cellular proteins isolated from 
melanocytes or co-cultures with melanocytes contain tyrosinase, which then 
hydroxylates the 
14
C tyrosine to DOPA, and oxidises the radiolabelled DOPA to 
DOPAquinone. The radioactive tyrosine is incorporated into DOPA and DOPAquinone 














tyrosinase enzyme activity, therefore the amount of incorporated radioactive tyrosine 
into these products are measured as an indication of tyrosinase activity. The 
incorporation of 
14
C tyrosine allows one to detect the melanin and its radiolabelled 
intermediates (Hearing et al., 1976, Oikawa et al., 1972). This assay was modified from 
the original protocol described by Hearing et al., 1976. Briefly, cells were cultured in 10 
cm diameter tissue culture dishes for 6 days in their respective ratios (Table 2.4). On 
day 6, cells were lifted with 0.05% EDTA (Appendix A.27), followed by trypsinisation 
with TE (Appendix A.28). Following centrifugation, the cell pellet was washed with 
PBS and transferred to a 1.5 ml microfuge tube on ice. The PBS wash procedure was 
repeated to remove all traces of medium, following which the pellet was re-suspended 
by vortexing in 0.1 M sodium phosphate buffer (pH 7.2, Appendix A.29) containing 
0.5% Triton X-100 (Appendix A.14) and 1 x cPIC (Roche Diagnostics, Germany; 
Appendix A.11) for approximately 1 min. The samples were repeatedly freeze-thawed 
in liquid nitrogen and then centrifuged at 12000 rpm at 4
o
C for 20 min. The supernatant 
was transferred to clean 1.5 ml microfuge tubes and stored at -80
o
C till needed. 
 
Once sample protein concentration was determined, 150 µg/ml was incubated in a 
14
C 
tyrosine (20 µCi/ml; American Radiolabeled Chemicals, USA) and 0.25 mM DOPA 
(Sigma-Aldrich, USA; Appendix A.31) solution at 37
o
C for 1 h. Samples were then 
transferred to glass microfiber filters with a diameter of 25 mm (Whatman, England) 
and left to air-dry. The microfiber filters have a specific size, therefore the radioactive 
tyrosine incorporated DOPA and DOPAquinone will bind to the filters.  Once dry, the 
discs were washed 3 times in 0.1 N HCl (Appendix A.32) at room temperature for 15 














final 5 min wash in acetone (Merck, RSA). These wash steps were performed to remove 
the radioactive tyrosine on its own, that were too small to bind to the filter discs. The 
discs were then placed in scintillation vials (Sigma-Aldrich, USA) and left to air-dry 
overnight. The following day, 5 ml scintillation fluid (Quicksafe A; Zinsser Analytic, 
Germany) was added to each vial and the samples were read on a Tri-Carb 2100 TR 
liquid scintillation analyser (Packard, USA). Results were expressed as counts per 
minute (cpm).     
 
2.6 Melanin assay 
 
The culmination of melanogenesis results in the production of a mixture of melanin 
(Fig. 1.4). The melanin assay quantifies the total amount of melanin in the co-cultures. 
This assay was performed as previously described (Oka et al., 1996). Briefly, cells were 
cultured as previously described (Table 2.4) for a period of 6 days. One million cells 
(1x10
6
) were centrifuged, the supernatant removed and the pellet washed with 1 x PBS. 
This process was repeated and the cell pellet was re-suspended in 1 ml NaOH (1 M; 
Appendix A.33) and heated to 100
o
C for 30 min on a heating block (AccuBlock Digital 
Dry Bath; Labnet International, USA) to destroy the cell membrane and solubilise the 
melanin to be measured. Samples were cooled to room temperature for 30 min, before 
being centrifuged at 16000 x g for 20 min. The supernatant was read at 400 nm on a 
spectrophotometer (Versamax microplate reader; Molecular Devices, USA) in triplicate. 
Results were compared to a standard curve prepared from synthetic melanin (prepared 
by oxidation of tyrosine with hydrogen peroxide; Sigma-Aldrich, USA). Results are 














2.7 Fluorescence-activated cell sorting (FACS) 
 
In order to analyse melanocytes for the melanin assay following a period of co-culture, 
melanocytes and keratinocytes were separated by cell size and granularity by means of a 
flow cytometer. However, before attempting to separate the co-cultures for analysis, 
mono-cultures of melanocytes and keratinocytes were trypsinised as previously 
described, centrifuged and the cell pellets resuspended in PBS. The cells were then 
counted and 1 x 10
6
 cells were transferred into 5 ml BD Falcon round-bottom tubes (BD 
Biosciences, USA), in 500 µl PBS. A “mixed” 1:1 ratio of keratinocytes to melanocytes 
was transferred into another tube. Cells were then sent through the FACSCalibur (BD 




Immunocytochemistry (ICC) is a method whereby proteins of interest can be visualised 
using antibodies targeted to a specific protein or antigen (Van Noorden et al., 1983). It 
is utilised in morphological analyses and in the detection of the location of the proteins 
or antigens, on cells adhered to glass coverslips or on sections of tissue. Microscopes 
are used to visualise the antibodies bound to the proteins of interest. The methodology 
described below utilises the indirect method to detect specific proteins/antigens. A 
primary antibody is added to the cells which will target the antigen, and then a 
secondary antibody, conjugated to a fluorophore, is added and will bind to the primary 
antibody. A fluorescent microscope is used to excite/stimulate the fluorophore and the 














both the dendricity (Chapter 2.9) and scratch (Chapter 2.10) assays. This was to 
enhance the visualisation of the melanocytes within the co-cultures. In the case of the 
scratch assays, ICC was performed to determine whether melanocytes were 
proliferating as they migrated into the denuded area following the scratch. The protocol 
used to stain the cells was modified from Cunningham (1994). Briefly, cells adhered to 
the 35 mm
2
 glass coverslips (from dendrite quantification and scratch assays) were 
fixed with 4% paraformaldehyde at room temperature for 15 min, then washed with 1 x 
PBS and permeabilised with 0.1% Triton X-100 (Appendix A.34) for 15 min, with a 
change of Triton X-100 after the initial 5 min. Following another PBS wash, the cells 
were then incubated with the primary antibodies (Table 2.6) diluted in 10% bovine 
serum albumin (BSA, Appendix A.35) - either MART-1 only, in the case of the dendrite 
quantification assay; or MART-1 with Ki-67 for the scratch assays. MART-1 is specific 
for the melanocytes as it binds to the transmembrane protein on the Stage I and II pre-
melanosomes (Coulie et al., 1994, Kawakami et al., 1994, Delevoye et al., 2011). Ki-67 
is a nuclear marker for proliferation (Scholzen et al., 2000). It is expressed in 
proliferating cells in the different stages of the cell cycle, except for cells in the resting 
G0 phase. After incubating on ice at 4
o
C for 30 min, unbound antibodies were washed 
off, followed by incubation with the secondary antibodies (Table 2.6) diluted in 10% 
BSA at 4
o
C for a further 30 min. Another wash was performed before the coverslips 
were mounted onto glass slides with mowiol containing n-propyl gallate (Appendix 
















2.9 Dendrite quantification assay 
 
One melanocyte can be in contact with approximately 36 keratinocytes (Fitzpatrick et 
al., 1963). This is due to their extensive dendrite unit. These cellular processes are the 
conduits for melanosome transfer from the melanocytes to keratinocytes. The 
transferred melanosomes would then provide keratinocytes protection against UVR. It 
has previously been shown that the dendrites increase in number and length following 
UVR. This is to accommodate for the increase in melanosome transfer (Friedmann et 
al., 1987). Thus, the quantification of dendrites can be used as an indicator for increased 
melanogenesis and hence, melanocyte differentiation (Kim et al., 2010). For this assay, 
cells were seeded onto 35 mm diameter (35 mm) tissue culture dishes for the 5:1 ratio, 
while 6 cm diameter (6 cm) dishes were used for both 10:1 and 20:1 ratios. After 4 days 
of culture, cells were then fixed in 4% paraformaldehyde and stained with the anti-
MART1 antibody (1 in 200 dilution, Table 2.6) to visualise the melanocytes. 
Immunofluorescent images were taken on an inverted fluorescent microscope (AxioVert 
200M; Carl Zeiss Microscopy, Germany) with the AxioCam HRm camera (Carl Zeiss 
Microscopy, Germany) and AxioVision version 4.8 software (Carl Zeiss Microscopy, 
Germany) at 100 x magnification. The number of dendrites per melanocyte was counted 
and the length of each dendrite measured using Image J software (version 1.43u; 
National Institutes of Health, USA). Melanocytes were counted in 10 random fields of 
view and dendrites measured starting from a central point in the nucleus radiating 
















Figure 2.1. Melanocytes stained with anti-MART-1 antibody (green) and nuclei stained with 
Hoechst 34580 (blue). Black lines originating from a central point in the nucleus to the tips of the 
dendrites indicate the measured lengths of each dendrite. 
 
Melanocytes were not counted or measured if the full length of a dendrite was not 
visible. The results were presented as average number of dendrites per melanocyte and 
average length of dendrite (µm) per melanocyte. 
 
2.10 Scratch assay 
 
A scratch assay is used to observe and measure the migration of cells into an area not 
populated by other cells. It is commonly used in wound healing models since it is a 
method to simulate a wounded area (Liang et al., 2007). In this project, we wanted to 
measure the migration of the cells in the different ratios and determine which ratio 
would provide a better wound healing outcome and the involvement of the melanocytes 
during wound closure. The cells, as described in Table 2.3, were pre-mixed in 1.5 ml 
microfuge tubes and seeded onto a 35 mm
2














culture dish) overnight. The cells were not allowed to overflow from the coverslip into 
the tissue culture dish, thereby creating a difference in the confluency level. The scratch 
was made in the centre of the coverslip with a 1 ml blue micropipette tip, with the aid of 
a ruler to ensure a consistent scratch (Fig. 2.2). Thereafter, the dishes were washed 
gently with medium to remove debris and floating cells. Medium was added to the 
dishes before images were taken on the light microscope (Olympus, Japan) with the 
Powershot S50 camera (Canon, Japan) at 100 x magnification. These are the “control” 
images (t=0). Images were then taken at subsequent time points (4, 8, 24 and 48 h) 











Figure 2.2. Diagram depicting the scratch assay 
 
Subsequent ICC images were taken with the AxioVert 200M fluorescence microscope 
(Carl Zeiss Microscopy, Germany), AxioCam HRm camera (Carl Zeiss Microscopy, 
Germany) and the AxioVision version 4.8 software (Carl Zeiss Microscopy, Germany). 





















The percentage of Ki-67 positive melanocytes at the wound edge was calculated 
(Equation 1) from 10 random fields of view per time point. The rate of wound closure 
into the denuded area was measured from the images taken on the light microscope 
using Image J (version 1.43u; National Institutes of Health, USA). Briefly, 6-10 
measurements were taken from at least 2 separate fields of view per time point. The 
average of these measurements was then compared to the average of the “control” 
images which were taken immediately after the scratch was performed (Fig. 2.3). The 





















Figure 2.3. Diagram to show how measurements were performed to determine rate of 
wound closure 
 
Control  Time point e.g. 24 hours 
Denuded area 
















2.11 Statistical analysis 
 
All data were presented as mean±SEM. One way analysis of variance (ANOVA) with 
Bonferroni post hoc test was used to determine the significance. A value of P<0.05 was 
considered significant. Data was analysed using two way ANOVA with significance set 
at P<0.05 for the scratch assays at different time points. All the graphs and statistics 
were performed using GraphPad Prism (Version 5.01, USA). 
 
2.12 Ethics approval 
 
Ethics approval was obtained for this project from the Faculty of Health Sciences 

















CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 Cell culture 
 
3.1.1 Optimising the mono- and co-culture growth of human melanocytes 
and keratinocytes 
 
The aims of this project were to promote melanogenesis in an in vitro culture system 
using 3 different ratios of keratinocytes to melanocytes. This as followed by an 
investigation into which of the ratios would produce an improved clinical outcome with 
respect to pigmentation and wound healing. Melanocytes and keratinocytes were 
isolated and cultured from human skin samples. Briefly, the skin samples were ethically 
obtained from circumcisions and plastic surgery (local hospitals, Cape Town). All the 
ethical considerations related to the project were approved by our institution (Human 
Research Ethics Committee of University of Cape Town, Reference no. 493/2009).  
Two methods were performed to isolate primary melanocytes and keratinocytes (Table 
3.1).  
 
Method 1 yielded very few melanocytes and no keratinocytes after 3 days of culture.  
This poor yield was unexpected as Minwalla et al. (2001) had previously used this 
method successfully. However, it should be noted the difference was that their method 
was performed by incubating the samples in trypsin at 37
o
C for 2 h, whereas in this 
study, the samples were incubated at 4
o
C overnight, which was used in our laboratory to 














processed skin samples used were not small enough. Reducing the size of the samples 
could therefore be a possible solution. In contrast, method 2 produced both melanocytes 
and keratinocytes from the skin samples. However, the keratinocytes obtained, 
struggled to be expanded to further passages as they either did not re-adhere to new 
















Cut samples into 3-5 mm strips 
Place into 0.25% trypsin in PBS 
Incubate at 4oC overnight 
Remove epidermis from dermis 
Transfer epidermis to 5ml, 10% FCS to inactivate 
trypsin 
Manually disaggregate epidermis into smaller pieces 
Transfer disaggregated epidermis to clean tubes 
Centrifuge at 2500 rpm for 2 min 
Resuspend pellet in 1 ml Greens (Table 2.2) 
Transfer 500 µl into a 25 cm2 collagen I coated Biocoat 
flasks (BD Biosciences, USA) 
Transfer the rest into a 6 cm diameter (6 cm) tissue 
culture grade petri-dish with FETI medium (Table 2.1) 
 
METHOD 2 
Cut samples into 3-5 mm strips 
Place in 0.5 mg/ml dispase II (Sigma-Aldrich, USA) in 
Hank’s buffered saline solution  
Incubate at 4oC overnight 
Remove epidermis from dermis 
Manually disaggregate epidermis into smaller pieces 
Transfer disaggregated epidermis into 5 ml, 0.25% 
trypsin/ 0.05% EDTA 
Incubate at 37oC for maximum of 15 min with gentle 
agitation every 5 min 
When solution becomes murky, add FCS to inactivate 
trypsin 
Use 1 ml micropipette tip, with approximately 3 mm 
of the end cut off, to triturate the solution to get most 
of the epidermal cells into suspension 
Centrifuge at 2000 rpm for 5 min 
Resuspend pellet in 1 ml Greens (Table 2.2) 
Transfer 500 µl into collagen I coated Biocoat flasks 
Transfer the rest into a 6 cm tissue culture grade petri-
dish with FETI medium (Table 2.1) 


























As the second method yielded better results, it was further optimised for the isolation of 
melanocytes, by passing the cell suspension through a 70 µM cell strainer (BD 
Biosciences, USA) before centrifuging. This step was included as some larger pieces of 
epidermis were not disaggregated into a single cell suspension following the 15 min 
enzymatic procedure. Geneticin (100 µg/µl), which targets the more proliferative cells 
in a culture, was also added to the primary melanocyte cultures after 5 days of culture to 
remove the morphologically distinct contaminating fibroblast cells (Fig. 3.2, arrows), 
resulting in a pure population of primary melanocytes (Fig. 3.3) (Costin et al., 2003).  
 
 
Figure 3.1. Phase contrast images of primary keratinocytes in culture. A) Healthy keratinocytes, 
B-D) Keratinocytes that were trypsinised and cultured onto a new Biocoat flask appears to be 
vacuolated (white arrows). Magnification: 200X (No scale bar was included due to digital 










































Figure 3.2. Human melanocyte culture derived from human skin samples. Evidence of fibroblast 
contamination can be observed (white arrows). Magnification: 200 X. 
D 
Figure 3.3. Culture of primary melanocytes. A and C) Melanocytes stained with the melanocyte-
specific melanosomal marker, MART-1, green; and nuclear stain, Hoechst 34580, blue.  B and D) 
Phase. A and B) Magnification: 200 X. Scale bar = 100 µm, C and D) Magnification: 400 X. Scale 

















To confirm the culture purity, cells were stained with the melanocyte-specific marker, 
MART-1, Fig. 3.3A and C, and compared to the unstained phase micrographs (Fig. 
3.3B and D). At higher magnification on phase contrast, it could be observed that some 
fibroblasts were not completely removed from the melanocyte cultures following the 
geneticin treatment (Fig 3.3C and D, white arrows).  
 
Despite numerous attempts at propagating the primary keratinocyte cultures, we were 
unsuccessful. This led to the decision to rather use a human keratinocyte-derived cell 
line (HaCaTs, a gift from Prof Fusenig, Germany) for all future experiments (Boukamp 
et al., 1988). HaCaTs are non-tumorigenic, spontaneously immortalised cells, which 
behave similarly to normal human keratinocytes (Fig. 3.4A). The cells were cultured in 
DMEM (Fig. 3.4B); however, this was changed to Greens medium (Fig. 3.4C) when the 









The cell morphology was similar between the 2 media and no abnormalities were 
observed when the keratinocytes were cultured in the Greens medium. The cells 
exhibited typical cobblestone-like appearance and were passaged every 3 days due to 
Figure 3.4. Primary keratinocyte cultures (A) compared to the human keratinocyte cell line, 
HaCaTs, cultured in B) DMEM and C) Greens medium. Magnification: 200 X 














their high proliferative ability (Boukamp et al., 1988, Wang et al., 2012). We did not 
test the proliferation rate of the cells in the different media, but we speculate that they 
are similar due to visual observations. However, future considerations could include 
growth curve assays of the cells in DMEM and Greens. It should be noted, however, 
that even though HaCaTs are similar to primary keratinocytes, the immortalised cells 
may behave differently and the data generated from these cell lines could differ to the in 
vivo environment. HaCaTs will be referred to as keratinocytes (Kc) for the rest of this 
thesis. 
 
3.1.2 Co-culture of melanocytes and keratinocytes 
 
Once the primary melanocytes were successfully isolated and propagated, co-culture 
experiments in different ratios were set up with the keratinocytes (Chapter 2, Tables 
2.3-2.5). Figure 3.5 shows the co-cultures at ratios of keratinocytes to melanocytes of 










B C A 5:1 20:1 10:1 
Figure 3.5. Phase contrast images of melanocyte (arrows) and keratinocyte co-cultures seeded at 














Expectedly, due to their individualistic nature, islands of melanocytes were not 
observed, indicating that the melanocytes were randomly interspersed between the 
keratinocytes. This showed that the melanocytes and keratinocytes were thoroughly 
mixed prior to seeding onto the culture dishes. Melanocytes, in mono-cultures have 
been previously shown to display either a bi- or tripolar phenotype, whereas in co-
cultures they display a poly-dendritic morphology (Herlyn et al., 2000, Hsu et al., 
2002). This was confirmed in our work through observation of the cells in mono-

















Figure 3.6. Morphology of melanocytes in A) mono-culture and B-F) co-culture. Melanocytes in 
mono-culture are bi- and tripolar, however in co-cultures with keratinocytes, melanocytes tend to 
display a poly-dendritic phenotype. Magnification: 200 X. Scale bar = 50 µm. 
P
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Similarly, melanocytes co-cultured with keratinocytes, displayed a poly-dendritic 
phenotype, similar to that observed in vivo, suggesting that the environment in which 
melanocytes are found plays an important role with regard to their phenotype (Hsu et 
al., 2002). Melanocytes in mono-cultures express several antigens, such as β3 integrin 
subunit and melanotransferrin, that are not typically expressed in vivo (Valyi-Nagy et 
al., 1993). Interestingly, when melanocytes are co-cultured with keratinocytes, these 
antigens that were previously present are lost (Hsu et al., 2002). 
 
3.2 Senescence-associated beta-galactosidase (SA-βgal) assay 
 
We observed that a percentage of the melanocytes in the cultures exhibited a different 
morphology. The melanocytes appeared to be flattened, i.e. no refractive ring 
surrounding the cell body; or, exhibited a “spider-like” appearance. The morphology of 
a cell can often provide an indication of the state of the cell. Cells that have become 
large and flat, or multi-nucleated often indicate senescence (Kuilman et al., 2010). 
Senescence is an irreversible process whereby cells lose the ability to proliferate 
(Debacq-Chainiaux et al., 2009, Cairney et al., 2012, Handayaningsih et al., 2012). 
Cells undergoing senescence can be detected by the SA-βgal assay (Chapter 2.3). SA-
βgal positive cells will have a “bluish” tinge in the cytoplasm following the staining 
procedure. Melanocytes were grown in mono- (Fig. 3.7) and co-cultures with 
keratinocytes; and, as observed in Figure 3.7D-F, certain melanocytes were larger and 
poly-dendritic. These cells were positive for βgal and hence, senescent. Several of the 














3.7A-C, E). Surprisingly, these βgal positive cells did not display the typical large and 


























Figure 3.7. SA-βgal staining of melanocyte mono-cultures. Melanocytes with the typical bipolar and 
tripolar phenotype (A-C) as well as those that are large and poly-dendritic (D-F) are positive for the 
βgal activity. White arrows indicate senescent cells. Black arrows indicate non-senescent cells. 














Senescent melanocytes were rarely found in the co-cultures (data not shown). A reason 
for this could be that the keratinocytes were secreting growth factors that prevented 
senescence, such as endothelin-1 (Hara et al., 1995). It appears that melanocytes rarely 
underwent senescence; however, it was difficult to detect senescence in the co-cultures. 
In future, it may be a suggestion to use the fluorescence method of detecting SA-βgal 
activity. Cells can be incubated with C12FDG, a βgal substrate, which becomes 
fluorescent following cleavage by βgal. This fluorescence detection is more sensitive 
and quantitative (Debacq-Chainiaux et al., 2009). 
 
3.3 Tyrosinase protein expression 
 
Tyrosinase, a key enzyme in the formation of melanin, is a marker of differentiated 
melanocytes (Opdecamp et al., 1997). Furthermore, it is a key enzyme in melanogenesis 
as it oxidises DOPA to DOPAquinone and following a number of further biochemical 
steps, results in the formation of melanin (Fig. 1.4). The other important aspect of 
tyrosinase is that its expression is melanocyte specific. Tyrosinase expression was 
analysed through western blotting techniques where the total cellular protein was 
extracted after 6 days of co-culture. Figure 3.8A shows a representative blot of 2 
independent experiments. The negative control was a pure culture of human 
keratinocytes (Kc) and as expected, no band was observed. The primary human 
melanocyte culture (Mc) was used as the positive control for tyrosinase expression (70-
80 kDa). The detection of the p38 protein (38 kDa) was used as an internal loading 
control in all experiments. Even though less protein was loaded for Mc (5 µg), it still 














µg of protein. The 3 ratios of keratinocytes: melanocytes were all positive for the 
tyrosinase protein expression with the 5:1 ratio showing a higher expression than the 
other ratios. However, the densitometric analysis shows no difference between any of 
the ratios (Fig. 3.8B). Densitometry showed a 3.4, 2.7 and 2.8 fold increase in the 5:1, 
10:1 and 20:1 ratios, respectively. The melanocyte control had the highest fold increase 
(7.9). Therefore, despite visually seeming different in the western blots, the 




















Figure 3.8. Western blot of tyrosinase and p38. A) Western blot confirms the presence of 
tyrosinase in the 3 different ratios of keratinocytes to melanocytes – 5:1, 10:1 and 20:1. Kc = 
keratinocyte only control, whereas Mc = primary human melanocyte. This is a 
representative of 2 independent experiments. B) Densitometry showing fold increase of 
tyrosinase expression when normalised to KC. 



















3.4 Tyrosinase enzymatic activity 
 
Despite the tyrosinase expression being non-significant between the different ratios, the 
question of tyrosinase enzymatic activity between the different ratios was investigated. 
This was done in order to find out if it correlated to tyrosinase protein expression and 
was conducted by way of a tyrosinase activity assay. The level of enzyme activity was 
quantified as counts per minute (cpm) of incorporated radioactive tyrosine in 150 µg of 
total protein. The data was normalised to the keratinocyte control. Figure 3.9 shows that 
similar amounts of enzyme activity were found between the 3 ratios. Unsurprisingly, the 
tyrosinase activity assay correlated with the tyrosinase western blot expression in that 
none of the ratios showed significance. The 5:1, 10:1 and 20:1 ratios showed a mean of 
1461.7±262.4, 1146.2±483.1 and 1097.2±677.3 cpm, respectively. The melanocyte 
(Mc) control exhibited the highest level of tyrosinase activity at 2165069±33794.1 cpm. 
Hence, the enzyme activity in the ratios appeared to be considerably lower than the 
control. As tyrosinase activity was detected in the ratios, it could be concluded that the 
melanocytes were actively synthesising melanin. However, the level of activity of 

















Figure 3.9. Enzyme activity of tyrosinase between the different ratios. Data is normalised to the 
keratinocyte control. The ratios of keratinocytes to melanocytes – 5:1, 10:1 and 20:1. Melanocyte 
(Mc) represents the positive control. Data is presented as mean±SEM, n=3. 
 
3.5 Melanin assay 
 
Despite no difference being observed in the level of tyrosinase enzyme activity, we next 
wanted to determine if there was a difference in the amount of melanin produced 
between the ratios. Regardless of numerous modifications to the protocol, several 
methodological problems were encountered. Firstly, the protocol involved lysing the 
cells and creating a pellet through centrifugation. However, we were unable to acquire a 
pellet after the centrifuge step. Secondly, there was debris in the supernatant which 
made the pipetting into 96-well plates for triplicate readings, difficult and inconsistent. 
This may have been due to the amount of keratinocytes in the samples as the 
melanocyte only control, showed no such characteristic. Therefore, further 
modifications were needed to quantify the amount of melanin in the co-cultures. 
 
One option was a “spiking” experiment to determine the sensitivity of this assay in 
detecting very low quantities of melanin. For this, up to 2 x 10
5
 melanocytes were added 




































 keratinocytes. Using an established protocol (Oka et al., 1996), our results 
confirmed that this assay was not sensitive enough to detect the low amount of melanin 
produced in the co-cultures (Fig. 3.10). The experiment shows the background reading 
of this assay is ± 4 µg/ml. Only the pure culture of melanocytes showed an increase in 
the concentration of melanin (± 9 µg/ml), whereas the spiking of the melanocytes 
showed similar levels of melanin to the keratinocyte only control (0 x 10
4
 melanocytes). 
This re-emphasised the difficulty of reading melanin in a co-culture system and 
highlighted the need for an alternative method to quantify and determine the pigmentary 
phenotype of the 3 co-cultures.  
 



























Figure 3.10. Melanocyte "spiking" assay. Melanocytes ranging from 0.1 to 20x10
4
 were added to 
1x10
6
 keratinocytes. The pure keratinocyte culture (0 melanocytes added) is the negative control, 
whereas a pure melanocyte culture (100x10
4
) is used as a positive control.  
 
In further support, many of the articles regarding melanin assays have been performed 
primarily on pure melanocyte/melanoma cultures or melanosome uptake experiments by 














the one group that used immortalised murine cell lines with a keratinocyte to 
melanocyte ratio of 5:1. However, after 6 days of co-culture, they found that the ratio 
became 2.5:1. Furthermore, they did not centrifuge the samples after the cells were 
lysed with NaOH. This, and including the higher ratio of melanocytes in their samples, 
probably allowed them to acquire reproducible, detectable melanin values. 
 
The next option was to culture the cells in different ratios and separate the melanocytes 
from the keratinocytes in order to repeat the western blot, tyrosinase assay and melanin 
assay analyses on each cell type. The rationale for this was that post-separation, a 
western blot would inform us if tyrosinase expression was found in the keratinocytes. If 
it was, the tyrosinase enzyme activity assay would determine if the enzyme was still 
active even after the transfer of melanosomes from the melanocytes. It was previously 
shown that tyrosinase activity was present in the melanosomes that were secreted into 
the culture medium by primary mouse melanocytes (Costin et al., 2003). 
Simultaneously, in light of the limitations to the melanin assay mentioned above, having 
an isolated population of melanocytes would allow us to perform the melanin assay 
without the interference of the keratinocytes in the samples. 
 
To separate the 2 cell types, we initially tried to “differentially” trypsinise the 
melanocytes from the co-cultures, as we knew from experience, that melanocytes lifted 
more readily than the keratinocytes. This trypsinisation method was no different to the 
normal trypsinisation method of the cells (Chapter 2.1.2). We confirmed the 
observations of Berens et al. (2005), in that this method was unsuccessful as not all of 














melanocytes in direct contact with the keratinocytes form very tight junctions with the 
keratinocytes (Tang et al., 1994, Haass et al., 2004).  
 
We next decided to sort the cells by size and granularity using fluorescence-activated 
cell sorting (FACS). The rationale behind this was that keratinocytes are larger than 
melanocytes, and that melanocytes are more granular than the keratinocytes due to the 
melanin/melanosomes in the cells. Surprisingly, we discovered that the pure melanocyte 
and keratinocyte cultures are very similar in size and granularity post-trypsinisation 















Figure 3.11. Forward scatter (FSC) and side scatter (SSC) of human melanocytes and 
keratinocytes, and a “mix” of melanocytes and keratinocytes. FSC relates to size of cells and 















A further approach was to stain one cell type with a cell-specific FACS-related antibody 
and proceed with cell sorting. The antibodies used were either the melanocyte-specific 
MART-1/MELAN-A, which targets the stage 1 and 2 melanosomes in the melanocytes 
(Delevoye et al., 2011); or a keratinocyte-specific cytokeratin antibody. During the 
FACS staining procedure, it was noticed that many cells were lost during the washing 
steps and the cells did not readily take up the antibody. This approach, due to time 
constraints was therefore, abandoned. 
 
3.6 Dendricity index 
 
Although the melanin assay was not definitive, it is established that the dendrite number 
and length of melanocytes correlate with an increase in melanin content and 
melanosome number (Friedmann et al., 1987). Based on this, we used the dendrite 
number and length as markers of melanogenesis/differentiated cellular state. The aim 
was to determine if there was a difference in the morphology of the melanocytes, with 
respect to i) the number of dendrites per melanocyte, and ii) the length of these 
dendrites in the co-cultures of the different ratios. The number of dendrites was 3.6±0.1, 
3.7±0.2 and 3.8±0.3 for 5:1, 10:1 and 20:1, respectively. The results show an average of 
4 dendrites per melanocyte for all 3 ratios (Fig. 3.12). The average length of each 
dendrite for 5:1, 10:1 and 20:1 was 68.8±2.4, 65.1±4.1 and 62.2±4.1 µm, respectively 



















































Figure 3.12. Dendricity index showing average number of dendrites per melanocyte in 10 randomly 




































Figure 3.13. Dendricity index showing average length of dendrites per melanocyte in 10 randomly 
selected fields of view. Data is presented as mean±SEM from 3 independent experiments. 
 
In an earlier study, Jungbauer et al. (2004) reported that the mean number of dendrites 
per melanocyte was 2.2. Our results showed a higher dendricity average, possibly as our 
assays were performed in co-cultures, compared to their mono-culture experiments. In 
our study, there was no significant difference between the 3 ratios for the number and 














quantity of melanin, irrespective of the keratinocyte to melanocyte ratio. This correlated 
with the fact that tyrosinase activity was not significantly different between the ratios. 
This further confirms that keratinocytes did not upregulate known factors that enhance 
melanogenesis such as α-melanocyte-stimulating hormone, prostaglandin E2 and 
endothelin-1, which are involved in pigmentation and dendricity of the melanocytes 
(Hunt et al., 1996, Scott et al., 2007, Hara et al., 1995, Imokawa, 2004).  
 
Microscopic analyses of these immunocytochemically-labelled co-cultures display a 
slightly different picture. Representative images of the different ratios taken at phase 
(Fig. 3.14A, C and E), as well as ICC images of MART-1 and Hoechst 34580 
(Invitrogen, UK) staining, are shown (Fig. 3.14B, D and F). Vacuoles (white arrows) 
within the keratinocytes can be observed in some of the cultures, which could be an 
indication of these cells undergoing senescence or apoptosis. Studies relating to 
senescence, suggests that cells display typical features, which include cells that are 
larger in size, irregularly shaped and contain many vacuoles within the cytoplasm (Kang 
et al., 2000, Soroka et al., 2008). Moreover, cells undergoing apoptosis display a 
shrinking of the cells, blebbing and vacuoles in the cytoplasm (Saraste et al., 2000, 
Abbro et al., 2003, Gonzalez-Polo et al., 2005). This appearance of vacuoles could also 
have been due to the lack of nutrients as HaCaTs are known to be very proliferative; and 
hence, could have depleted the available nutrients (Boukamp et al., 1988). This assay 
was set up with a constant melanocyte number, therefore the keratinocyte number 
increased from 5 x 10
4
 to 2 x 10
5
. Because of the high total cell number, we were 
concerned that 35 mm tissue culture dishes would become too confluent after a period 














could be that the cells were either too confluent (for the 5:1 ratio) or sparse (for the 10:1 
and 20:1 ratios) as different sized tissue culture grade dishes were used to culture the 





















Figure 3.14. Representative images of the different keratinocyte to melanocyte ratios. A, C and E) 
Phase contrast; B, D and F) melanocyte-specific MART-1 (green) and Hoechst 34580 (nucleus, 
blue). White arrows indicate vacuoles observed in the keratinocytes. Magnification: 100 X. Scale 
























Cells grown in culture have been known to have contact inhibition, where cell growth is 
arrested, due to the cells being too close to one another (Seluanov et al., 2009). Cells 
also do not grow in an environment where they are too far apart as they lose the cell-to-
cell contact, and therefore, cannot communicate with each other (Rubin et al., 1973). 
Future dendricity assays could be performed with the same cell numbers and in 35 mm 
tissue culture dishes, however, with increased volume of medium, or the medium could 
be changed after 2 days of co-culture. Another suggestion could be to reduce the 
melanocyte cell number, which will in turn decrease the total cell number and therefore, 
alleviate the problem of over-confluency. 
 
The data generated thus far, points to the fact that normal melanogenesis takes place in 
all 3 ratios. Moreover, as there was no difference in the ratios, it can be assumed that the 
pigmentary phenotype was identical. In summary, the keratinocytes did not affect 
tyrosinase processing and enzyme activity, and therefore melanogenesis. The 
keratinocytes also did not affect the morphology of the melanocytes, with regard to the 
dendricity of the cells. Finally, we determined that the melanin assay was too insensitive 
to detect the melanin in our co-culture system. A few suggestions to overcome this, is to 
isolate and quantify melanosomes, or to use more advanced high-performance liquid 


















3.7 Scratch assay 
 
In order to investigate the pigmentary phenotype of the 3 different co-cultures, this 
project looked at tyrosinase enzyme expression and activity, and the quantification of 
dendricity. Now that we have shown that all 3 ratios exhibit a similar level of 
pigmentation, we wanted to determine which of the 3 ratios would provide an optimal 
wound healing outcome and whether there was, if any, involvement of the melanocytes 
during wound closure. Hence, scratch assays were performed to observe the migration 
and proliferation of cells into a wounded area. The percentage of wound closure was 
determined over a 4 to 48 hour period (Fig. 3.15).  
 




































Figure 3.15. Percentage wound closure at 4, 8, 24 and 48 hours after the scratch.  When the wound 
was made (0 h), wound closure was 0 %. Ratios are represented as keratinocytes: melanocyte, Kc = 
keratinocyte control, Mc = melanocyte control. Data is shown as mean±SEM of 3 independent 
experiments. The percentage wound closure at 24 h time points were compared to the 4 h time 
points of each ratio or control, *P<0.05. Each Mc time point was compared to the corresponding 
time points of the ratios or Kc control, †P<0.001. 
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Creating the wound on the dish at time 0 h was defined as 0 % and progressive wound 
closure was normalised as a percentage against the initial wound (0 %). At 4 and 8 h 
after the scratch was made, wound closure was minimal and no significant differences 
were observed. The percentage of wound closure ranged from 5.9 to 8.7 % for the 4 h 
time point, whereas wound closure was 5.4 to 16 % for the 8 h time point between the 
ratios and the controls. The rate of wound closure occurred more rapidly between 8 h 
and 24 h after the scratch was performed. At 24 h post-wounding, the rate of closure 
ranged from 61.4 to 72.6 % between the 3 ratios and the keratinocyte control. These 
values were significantly different compared to their 4 h time points (*P<0.05). The rate 
of wound closure of the melanocyte control was 28.9 %. This was significantly different 
to the 3 ratios and the keratinocyte control (†P<0.001). The results showed that the 
migration of melanocytes in the mono-cultures was slower than the keratinocytes. 
However, in the presence of keratinocytes, the rate of migration was increased as the 
melanocytes were demonstrated to be in the edge of the migrating keratinocytes (Fig. 
3.16). This implied that the keratinocytes are the source of migratory and proliferative 
factors, such as tumor necrosis factor-alpha, basic fibroblast growth factor and 
transforming growth factor-beta, during wound healing (Gauglitz et al., 2012). We, 
therefore, suggest a theory that keratinocytes signal to the melanocytes to migrate into 
the wound in the co-cultures. However, in the absence of keratinocytes, there is a lack 
of signalling molecules to recruit the melanocytes into the wounded area. The rate of 
wound closure 48 h after the scratch was made, was 100 % for the 5:1, 10:1, 20:1 ratios 
and the Kc control. The wound closure at 48 h for the Mc control was 38.5 %. This was 














involvement of keratinocytes in wound healing is important as it is involved in complete 





















 Figure 3.16. Scratch assay images in phase contrast microscopy (left panels) and MART-1 
staining (right panels) of 5:1 ratio over a period of 24 hours. This is a representative image 
for all the ratios. The 10:1 and 20:1 ratio scratch assays were not shown as no difference was 



















Representative phase and ICC images of the scratch assay at the different time points 





























Figure 3.17. Scratch assay images at 24 h post-scratch, showing the wound closure of the ratios 














As observed, wound closure at 4 h and 8 h was minimal. At 8 h, the melanocytes have 
migrated into the wound and lined up against the border of the keratinocytes. This was 
similar to previous work in our laboratory (Keswell et al., 2012). Although not shown, 
it is interesting to speculate that at this stage, the keratinocytes are secreting specific 
factors in response to injury, such as interleukin-1 (IL-1). IL-1 is secreted by 
keratinocytes during wound healing where it induces an autocrine response leading to 
keratinocyte migration and proliferation (Kiwanuka et al., 2012). The effects of IL-1 on 
melanocytes, however, has a dual role in that, it i) attracts the melanocytes to repopulate 
the wound with the migrating and proliferating keratinocytes and thereby not lose the 
ratio of melanocytes to keratinocytes and ii)  decreases melanocyte proliferation and 
melanogenesis in vitro, thus keeping the melanocytes in an undifferentiated, migratory 
state (Swope et al., 1991). Future work could include determining the level of IL-1 
RNA and protein expression in the scratch assays. 
 
Valyi-Nagy et al. (1993) demonstrated that the initial seeding ratio of melanocytes to 
keratinocytes remain constant, even after several days in co-culture. In contrast, our 
study showed that the initial seeding ratio does not remain constant. The cells used in 
this study exhibited different proliferative rates - the HaCaTs are highly proliferative 
cells with a doubling time of 18-20 h, whereas the primary human melanocytes have a 
doubling time of 2-3 days (Boukamp et al., 1988, Wang et al., 2012, Valyi-Nagy et al., 
1993, Boukamp et al., 1990, Alexaki et al., 2012). In support of our data, Lei et al. 
(2002) in their murine cell culture model showed that the initial seeding ratio changed 
after several days in co-culture. The dual functionality of IL-1 is interesting as 














proliferation, it allows for melanocytes to focus on migration (Zheng et al., 2009). 
Melanocytes at the 24 h time point were either lagging a few cells behind the 
keratinocyte wave, directly in front of the keratinocytes or both (Fig. 3.17).  
 
This is in contrast to Heath et al. (2009), who showed that melanocytes in vivo were not 
present in the migrating epithelial tongue. Furthermore, they noticed that melanocytes 
were found in the newly epithelialised wound, lagging behind the keratinocytes by 0.45 
– 2.85 mm. However, they do not mention if the melanocytes were being “carried” by 
the keratinocytes as the keratinocytes proliferated and migrated to close the wound; or, 
whether the melanocytes migrated into the wounded area once it has been fully/partially 
re-epithelialised. In recent work, our group demonstrated that the melanocytes are able 
to migrate through tightly bound keratinocytes (Keswell et al., 2012). Moreover, we 
showed melanocytes migrating into the wounded area, “leading” the keratinocytes. In 
addition, melanocytes became bipolar with “dendrites protruding into the spaces” 
(Keswell et al., 2012). Similarly, our scratch assays displayed the same phenotype 
where many of the melanocytes were bipolar with one arm of the dendrite “pointing” 
towards the wounded area. A possible reason for this could be that dendrites were a 
mechanism for finding a path through the keratinocytes. The dendrites would extend 
and once the pathway has been found, it would then attach to the keratinocytes and both 
the cell body and the nucleus are pulled through between the tightly packed 
keratinocytes (Keswell et al., 2012). Alternatively, as suggested by Chadwick et al. 
(2012) that in order to reduce oxidative stressors, a response to wound healing, 
melanocytes would quickly repopulate the wounded area, to scavenge the free radicals 














As the proliferation of melanocytes in and around the wound bed is a rare event, the 
objective was to investigate how these cells were affected in the presence of 
keratinocytes. To do this, immunocytochemistry was utilised and the co-cultures were 
stained with MART-1 (melanocyte-specific) and Ki-67 (proliferation marker) 
antibodies. An example of melanocytes (green, MART-1
+
) that are either proliferating 
(red, Ki-67
+
) or not proliferating (Ki-67
-
) is shown in Figure 3.18.  
 
 
Figure 3.18. Example of the Ki-67 and MART-1 double staining. Melanocytes are stained green 
(MART-1+). Proliferating melanocytes were green with a red nucleus (Ki-67+). Non-proliferating 
melanocytes do not have a nuclear stain (Ki-67-). Keratinocytes are represented by a Ki-67
+
 
nucleus. Magnification: 400 X. Scale bar = 50 µm. 
 
Quantifying the percentage of proliferating melanocytes in the periphery of the wound 
over time showed no significant reduction in cell proliferation in any of the ratios used. 
The percentage of Ki-67 positive melanocytes ranged from 55.2 to 76.2% between 0 














edge to determine their involvement during wound healing, no significant differences 
were found between the 3 ratios or the time points. This suggests that despite one 
particular cell type (melanocytes) entering the wound bed before the other 
(keratinocytes), no difference in the rate of proliferation occurs, irrespective of the 
number of surrounding keratinocytes. This is interesting in light of the fact that one 
would assume that with increasing keratinocytes in the surrounding environment, more 
proliferative factors may be released. This suggests therefore, that either the 
keratinocytes in a “wound-healing” situation down-regulates their own factors, or the 
melanocytes induce a down-regulatory effect at an autocrine level (on themselves) 
and/or paracrine level (on the keratinocytes). 
 


























Figure 3.19. Percentage of proliferating melanocytes close to the wound edge. The number of Ki-67 
positive melanocytes was counted and normalised against the total melanocytes in 10 fields of view. 















Although the specific mechanism of melanocyte migration into wounded skin is not 
known, 2 theories exist - either the melanocytes migrate with the keratinocytes into the 
wound or, the melanocytes repopulate the wound once it has been re-epithelialised by 
the keratinocytes. Contrasting evidence has been shown regarding the migration of the 
melanocytes (Chadwick et al., 2012, Breathnach, 1960). Heath et al. (2009) established 
that the migrating epithelial tongue did not contain any melanocytes. But, the 
melanocytes were, in fact, migrating into the wounded area. They were observed to be 
lagging behind the leading edge by 2-3 mm. However, in our system, we observed that 
the melanocytes remained in front of the keratinocytes in the wounded area at the 8 and 
24 h time points. It must be borne in mind though, that our experiments were performed 




























CHAPTER 4: CONCLUSION 
 
Annually, 3.2 % of the population is burned in South Africa. This percentage is 
proposed to increase in time to come due to factors such as poverty, increased 
establishment of informal shacks and the usage of open, unattended fires. The most 
commonly burned areas on the body are the face, hands and feet. Clinical treatment 
options including autologous cellular grafting are available. However, because the 
priority to surgeons is mainly concerned with the closure of the wound, keratinocytes 
are the predominant cell type grafted onto the burned areas. The absence of melanocytes 
therefore leads to an insufficient amount of melanin in these grafted regions. Thus, 
when the wound is completely healed, it remains hypopigmented. This results in a 
number of psychosocial consequences, such as depression, stigmatism, discrimination 
and low self-esteem. The presence of melanin in the skin is crucial, not only for 
aesthetics, but because it protects the skin cells and their nuclei from UVR damage.  
 
The overall aim of this study was to use 3 different ratios of melanocyte to keratinocyte 
co-cultures to analyse their ability to promote melanin synthesis. This was performed in 
order to suggest whether these contributed to improved wound healing and pigmentary 
outcome in burn wounds. We have shown in terms of pigmentary phenotype, 
surprisingly, all 3 ratios produced similar quantities of tyrosinase protein expression and 
activity. This suggested that the same amount melanin was produced in the ratios, 
therefore the keratinocyte cell number did not affect melanogenesis. In addition, no 














melanocytes in the co-cultures showed an average of 4 dendrites per cell and each 
dendrite was approximately 65 µm in length. As the morphology of the cells did not 
change in the different ratios, it was in fact not unexpected that with the same tyrosinase 
expression and activity, we speculate that melanin content was the same. There was no 
difference in the rate of wound closure between the ratios; however, melanocyte mono-
cultures required more than 48 h to close the wound completely. This information is an 
important contribution to the clinical field where the optimal outcome includes an 
evenly pigmented wound. The involvement of melanocytes with regard to the 
quantification of proliferating melanocytes in the periphery of the wound showed that 
there were no differences between the ratios and the time points that were investigated. 
This suggested that keratinocytes did not produce inhibitory factors that affected the 
growth of melanocytes. Furthermore, melanocytes not only migrated into the wounded 
area, but proliferated to increase the melanocyte population in the re-epithelialised skin. 
This work also showed that even though melanocytes exhibited enlarged, flattened cell 
morphology, this does not necessarily equate to senescence. Finally, it must be made 
aware that future work using the melanin assay to quantify melanin, may not be 
sensitive enough to detect the minute quantity of melanin in co-cultures and suggests 
that it is cell number dependent. For future consideration, alternative methods for 
melanin detection could include the use of high performance liquid chromatography or 

















 4.1 Future directions  
 
This study provides the foundation for further experiments in the field of pigmentation 
research and its translation to the clinical applications of wound healing medicine. Such 
studies could include determining which factors are secreted during wound healing to 
stimulate the proliferation, migration and melanin production of the melanocytes. It 
could be of importance to increase these specific factors to enhance the involvement of 
melanocytes to improve repigmentation in the wounded area. Furthermore, it would be 
of interest to investigate the involvement of melanocytes between the 8 and 48 h time 
period as in our scratch assay, most of the cellular activity occurred between these time 
points.  
 
The data obtained through this study are of relevance as it can be translated to the 
clinical environment. Overall, the knowledge generated can be used to improve the 
efficacy of autologous cellular grafting in the treatment of partial-thickness burn 
wounds. Since no differences were observed in the 3 ratios in terms of pigmentation and 
wound healing, we can suggest that a ratio of 20 keratinocytes to 1 melanocyte be used 
in the treatment of partial-thickness burn wounds. This is an advantage as it implies that 
fewer melanocytes would be required to repigment the wounded area. Therefore, a 
smaller donor area is needed to obtain a sufficient quantity of melanocytes in the 
treatment, thus reducing the traumatic experience for these burn patients. However, this 
research is ongoing and investigations such as these are important to continue to 
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Quantity sufficient (qs) is defined as enough liquid (e.g. ddH2O) that is used to make up 
a certain (final) volume of the solution given in liters (L) or milliliters (ml) 
 
A.1 10000 U/ml Penicillin/10000 µg/ml Streptomycin (100 x, 1 L) 
 
Penicillin (Sigma-Aldrich, USA)      6 g 
Streptomycin (Sigma-Aldrich, USA)      10 g 
Autoclaved double distilled water (ddH2O)     qs 
Sterilise through a 0.2 µm filter and store in aliquots at -20
o
C 
Use at 1 x dilution, after thawing 
 
A.2 Hanks Buffered Salt Solution (HBSS, 1 L) 
 
HBSS powder (Highveld Biological, RSA)     9.5 g 
NaHCO3 (Merck, RSA)       0.35 g 
ddH2O          qs 
 
A.3 Phosphate Buffered Saline (PBS, 1 L) 
 
NaCl (Merck, RSA)        8 g 
Na2HPO4 anhydrous  (Merck, RSA)      1.26 g 
KCl (Merck, RSA)        0.2 g 
KH2PO4 (Merck, Germany)       0.2 g 
ddH2O          qs 















A.4 0.25% Trypsin/ 0.05% Ethylenediaminetetraacetic acid (EDTA, 
100 ml) 
 
Trypsin (BD Biosciences, USA)      0.25 g 
EDTA anhydrous (Sigma-Aldrich, USA)      0.05 g 
PBS (Appendix A.3)        qs 




A.5 Dulbecco’s Modified Eagle’s Medium (DMEM, 2L) 
 
DMEM powder (Highveld Biological, RSA)     27.06 g 
NaHCO3         7.4 g 
Autoclaved ddH2O        qs 
Adjust to pH 7.2-7.4 




Additives: 10% heat-inactivated fetal calf serum (FCS, Highveld Biological, RSA) 
  100 U/ml penicillin/ 100 µg/ml streptomycin (1 x, Appendix A.1) 
 
A.6 4% Paraformaldehyde (PFA, 100ml) 
 
Paraformaldehyde (Merck, Germany)     4 g 
PBS          qs 
Heat at 50
o






















A.7 βgal Stain 
 
Potassium ferrocyanide K3Fe(CN)6 (Sigma-Aldrich, USA)   5 mM  
Potassium ferricyanide K4Fe(CN)6.3H2O (Sigma-Aldrich, USA)  5 mM  
MgCl2 (Merck, RSA)        2 mM  
X-gal (PEQLAB Biotechnologie, Germany)     1 mg/ml 
PBS (1 x) pH 6        qs 
 
A.8 Mowiol  
 
Mowiol (Sigma-Aldrich, USA)      2.4 g 
Glycerol (Merck, RSA)       6 g 
Tris buffer (0.2 M) pH 8.5 (Appendix A.9)     12 ml 
ddH2O          6 ml 
Stir for a few hours at 50
o
C 
Centrifuge at 12000 rpm for 20 min 
Store supernatant in 1 ml aliquots at -20
o
C  
A.9 0.2 M Tris pH 8.5 (100 ml) 
 
Tris (Merck, Germany)       2.42 g 
ddH2O          qs 
Adjust to pH 8.5 
 
A.10  Complete Radio-immunoprecipitation Assay (RIPA) Buffer 
 
Complete Proteinase Inhibitor cocktail (cPIC, Appendix A.11)  1 x 
Aprotinin (Roche Diagnostics, Germany)     1 µg/ml 
PMSF (Sigma-Aldrich, USA)       0.5 mM 
Pepstatin A (Roche Diagnostics, Germany)     1 µg/ml 














A.11  cPIC (25 x) 
 
cPIC tablet (Roche Diagnostics, Germany)     1 tablet 
ddH2O          2 ml 
Aliquot and store at -20
o
C 
Use at 1x 
 
A.12  Incomplete RIPA Buffer  
 
NaCl (Appendix A.13)       150 mM 
Triton X-100 (Appendix A.14)      1% 
Sodium dodecyl sulfate (SDS, Appendix A.15)    0.1% 
Tris (pH 7.5)         20 mM 
Deoxycholic acid (Sigma-Aldrich, USA)     1% 
ddH2O          qs 




A.13  0.5 M NaCl (100 ml) 
 
NaCl (Merck, RSA)         1.46 g 
ddH2O          qs 
Dilute to necessary concentration with ddH2O 
 
A.14  20% Triton X-100 (1 ml) 
 
Triton X-100 (Sigma-Aldrich, USA)      200 µl 
ddH2O          800 µl 
Dilute to necessary concentration with ddH2O (for incomplete RIPA buffer) or 0.1 M 















A.15  10% SDS (40 ml) 
 
SDS (Sigma-Aldrich, USA)       4 g 
ddH2O          qs 
Dilute to necessary concentration with ddH2O 
 
A.16  Loading dye (5 x, 20 ml) 
 
Tris (1 M) pH 6.8 (Appendix A.17)      6 ml 
Glycerol (Merck, RSA)       10 ml 
2-β mercaptoethanol (Sigma-Aldrich, USA)     4 ml 
Bromophenol blue (Sigma-Aldrich, USA)     pinch 
SDS           2 g 
Aliquot and freeze at -20
o
C 
Use at 1 x concentration  
 
A.17  1 M Tris pH 6.8 (100 ml) 
 
Tris          12.11 g 
ddH2O          qs 
Adjust pH to 6.8 
 
A.18  10% SDS-PAGE (20 ml) 
 
Acrylamide (30%; Sigma-Aldrich, USA)     6.6 ml 
Tris (1.5 M) pH 8.8 (Appendix A.19)     5 ml 
ddH2O          8.2 ml 
SDS (10%, Appendix A.15)       200 µl 
APS (10%, Appendix A.20)       100 µl 















A.19  1.5 M Tris-HCl pH 8.8 (100 ml) 
 
Tris          18.17 g 
ddH2O          qs 
Adjust to pH 8.8 
 
A.20  10% Ammonium persulfate (APS) 
 
APS (Promega, USA)        100 mg 





A.21  4% stacking gel (10 ml) 
 
Acrylamide (30%; Sigma-Aldrich, USA)     1.3 ml 
Tris-HCl (1M) pH6.8 (Appendix A.17)     2.5 ml 
ddH2O          6.1 ml 
SDS (10%)         100 µl 
APS (10%)         50 µl 
N, N, N’, N’-Tetramethylethylenediamine (Sigma-Aldrich, USA)  5 µl 
 
A.22  Running buffer (2 L) 
 
Glycine (Merck, RSA)       28.8 g 
Tris          6 g 
SDS           2 g 

















A.23  1 x Transfer buffer (1 L) 
 
Transfer buffer (10 x, Appendix A.24)     100 ml 
Methanol (Merck, RSA)       200 ml 
ddH2O          700 ml 
   
A.24  10 x Transfer buffer (1 L) 
 
Glycine         112 g 
Tris          24 g  
ddH2O          qs 
 
A.25  Tris-buffered saline-Tween 20 (TBS-T, 1 L) 
 
Tris          6.05 g 
NaCl          8.76 g 
ddH2O          qs 
Adjust to pH 7.5 
Tween 20 (Sigma-Aldrich, USA)      1 ml 
 
A.26  5% milk in TBS-T (10 ml) 
 
Fat-free instant milk powder (Elite, Clover, RSA)    0.5 g 
TBS-T          qs 
 
A.27  0.05% Ethylenediaminetetraacetic acid (EDTA, 100 ml) 
 
EDTA anhydrous (Sigma-Aldrich, USA)      0.05 g 
PBS          qs 

















A.28  0.05% Trypsin/ 0.02% EDTA (TE, 100 ml) 
 
Trypsin (BD Biosciences, USA)      0.05 g 
EDTA anhydrous        0.02 g 
ddH2O          qs 




A.29  0.1 M Sodium Phosphate Buffer (100 ml) 
 
Sodium phosphate buffer (1 M, Appendix A.30)    10 ml 
ddH2O          90 ml 
Adjust pH to 7.2 
 
A.30  1 M Sodium Phosphate Buffer (200 ml) 
 
NaH2PO4.2H2O (BDH Chemicals, UK)     15.6 g  
Na2HPO4.12H2O (Merck, Germany)      35.8 g  
ddH2O          qs 
Adjust pH to 7-7.4  
 
A.31  0.25 mM DOPA (10 ml) 
 
L-DOPA (Sigma-Aldrich, USA)      0.0005 g 
Sodium phosphate buffer (0.1 M)      10 ml 
 
A.32  0.1 N HCl (1 L) 
 
HCl (37%; Merck, RSA)       9.9 ml 















A.33  1 M NaOH (40 ml) 
 
NaOH (Merck, RSA)        1.6 g 
ddH2O          qs 
 
A.34  0.1% Triton X-100 (20 ml) 
 
Triton X-100         20 µl  
PBS          20 ml 
 
A.35  10% Bovine Serum Albumin (BSA) in PBS (20 ml) 
 
Albumin, from bovine serum (Sigma-Aldrich, USA)   2 g 
PBS          20 ml 
 
A.36  Mowiol with anti-fade  
 
Mowiol         1 ml 
n-Propyl gallate (Sigma-Aldrich, USA)    tip of a small spatula 
Vortex and heat at 50
o
C for 1 h, mixing occasionally 
Centrifuge at 13000 rpm for 15-20 min 
Transfer supernatant to clean tube and store at -20
o
C 
 
 
